Pharmacology

Action Mechanism of Action Reference
INHIBITOR Interleukin-23 inhibitor PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Psoriasis 4 D011565 FDA
Neoplasms 2 D009369 ClinicalTrials
Prostatic Neoplasms, Castration-Resistant 1 D064129 ClinicalTrials

Cross References

Resources Reference
CAS NUMBER 1326244-10-3
ChEMBL CHEMBL2108681
FDA SRS DEW6X41BEK
Guide to Pharmacology 8093